Can-Fite BioPharma Ltd. (TLV:CANF)
Israel
· Delayed Price · Currency is ILS · Price in ILA 1.300
-0.100 (-7.14%)
May 13, 2025, 5:24 PM IDT
Can-Fite BioPharma Market Cap
Can-Fite BioPharma has a market cap or net worth of 50.61 million as of May 13, 2025. Its market cap has increased by 30.02% in one year.
Market Cap
50.61M
Enterprise Value
22.26M
Revenue
2.45M
Ranking
n/a
PE Ratio
n/a
Stock Price
1.30
Market Cap Chart
Since June 12, 2006, Can-Fite BioPharma's market cap has increased from 16.04M to 50.61M, an increase of 215.56%. That is a compound annual growth rate of 6.26%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Teva Pharmaceutical Industries | 73.61B |
| Danel (Adir Yeoshua) | 2.35B |
| Kamada | 1.39B |
| Bait Bakfar | 1.15B |
| Novolog (Pharm-Up 1966) | 779.55M |
| SofWave Medical | 722.24M |
| Ilex Medical | 680.80M |
| BrainsWay | 586.43M |